Skip to content

Gut Hormones as Mediators of Different Weight Loss Responses After Roux-en-Y Gastric Bypass

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02374632
Enrollment
40
Registered
2015-03-02
Start date
2014-10-31
Completion date
2017-06-30
Last updated
2017-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bariatric Surgery (Gastric Bypass), Severe Obesity

Brief summary

After gastric bypass, 10-20% of patients will obtain a suboptimal weight loss, often defined as \<50% of the excess body weight. Exaggerated meal related secretion of gut hormones seem important for appetite reduction and subsequent weight loss after gastric bypass, however it is not clear whether different gut hormone responses are responsible for different postoperative weight loss responses. The purpose of the study is to investigate gut hormone secretion, vagal integrity and the effect of octreotide on ad libitum food intake in patients with suboptimal weight loss after gastric bypass and compare results to a matched group of gastric bypass operated patients with high postoperative weight loss but similar age, sex and preoperative BMI.

Interventions

OTHERMeal tests after saline injection

Fixed breakfast meal and ad libitum lunch meal

OTHERMeal tests after octreotide injection

Fixed breakfast meal and ad libitum lunch meal

Sponsors

University of Copenhagen
CollaboratorOTHER
Hvidovre University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
20 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Uncomplicated primary Roux-en-Y gastric bypass \>12 months ago * Postoperative weight loss of \>60%EBL or \<50%EBL.

Exclusion criteria

* Inadequately treated thyroid disease * Hemoglobin \<6.5 mM * Pregnancy or breastfeeding

Design outcomes

Primary

MeasureTime frameDescription
Glucagon-like peptide-1 (GLP-1) secretion (Between groups difference in incremental Area-under-the curve (iAUC) GLP-1 after fixed breakfast meal on saline day)0-240 minBetween groups difference in iAUC GLP-1 after fixed breakfast meal on saline day
Ghrelin secretion (Between groups difference in iAUC Ghrelin after fixed breakfast meal on saline day)0-240 minBetween groups difference in iAUC Ghrelin after fixed breakfast meal on saline day
Peptide YY (PYY) secretion (Between groups difference in iAUC PYY after fixed breakfast meal on saline day)0-240 minBetween groups difference in iAUC PYY after fixed breakfast meal on saline day

Secondary

MeasureTime frameDescription
Ad libitum food intake240 minBetween groups difference in ad lib food intake
Effect of octreotide on Ad libitum food intake (Between groups difference in %change in ad lib food intake between saline and octreotide day)240 minBetween groups difference in %change in ad lib food intake between saline and octreotide day
Vagal insufficiency (Between groups difference in % change in pancreatic polypeptide (PP) from fasting to early peak levels (15-30 min) after sham feeding)0-30 minBetween groups difference in % change in PP from fasting to early peak levels (15-30 min) after sham feeding

Other

MeasureTime frameDescription
Gut microbiota (Between groups differences in gut microbiome investigated with next generation sequencing)feces sample at home before interventionBetween groups differences in gut microbiome investigated with next generation sequencing
Genetic profile (Between groups differences in gene variants investigated with a HumanCoreExome chip)0 minBetween groups differences in gene variants investigated with a HumanCoreExome chip
Food intake (Between groups differences in food intake evaluated by questionnaires and diet registration)4 weeks questionnaires and 4 days of registrationBetween groups differences in food intake evaluated by questionnaires and diet registration
Physical activity (Between groups differences in food intake evaluated by questionnaires and accelerometer)4 weeks questionnaires and14 days of registrationBetween groups differences in food intake evaluated by questionnaires and accelerometer
Appetite scores (Between groups differences in VAS scores after meal test and sham feeding test)0-240 min, 240-270 min, 0-75 minBetween groups differences in VAS scores after meal test and sham feeding test

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026